Your browser doesn't support javascript.
loading
EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia.
Roessner, Philipp M; Llaó Cid, Laura; Lupar, Ekaterina; Roider, Tobias; Bordas, Marie; Schifflers, Christoph; Arseni, Lavinia; Gaupel, Ann-Christin; Kilpert, Fabian; Krötschel, Marit; Arnold, Sebastian J; Sellner, Leopold; Colomer, Dolors; Stilgenbauer, Stephan; Dietrich, Sascha; Lichter, Peter; Izcue, Ana; Seiffert, Martina.
Afiliação
  • Roessner PM; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Llaó Cid L; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lupar E; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.
  • Roider T; Max-Planck-Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Bordas M; Cellzome, Heidelberg, Germany.
  • Schifflers C; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
  • Arseni L; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Gaupel AC; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.
  • Kilpert F; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Krötschel M; Cell Biology Research Unit (URBC)-Namur Research Institute of Life Science (Narilis), University of Namur, Namur, Belgium.
  • Arnold SJ; Immunotherapy and Immunoprevention, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sellner L; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Colomer D; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Stilgenbauer S; Max-Planck-Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Dietrich S; Essen University Hospital, Institute of Human Genetics, Genome Informatics, Essen, Germany.
  • Lichter P; Max-Planck-Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Izcue A; BioMed X Institute, Heidelberg, Germany.
  • Seiffert M; Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Leukemia ; 35(8): 2311-2324, 2021 08.
Article em En | MEDLINE | ID: mdl-33526861

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Leucemia Linfocítica Crônica de Células B / Linfócitos T CD4-Positivos / Interleucina-10 / Linfócitos T Reguladores / Células Th1 / Proteínas com Domínio T Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Leucemia Linfocítica Crônica de Células B / Linfócitos T CD4-Positivos / Interleucina-10 / Linfócitos T Reguladores / Células Th1 / Proteínas com Domínio T Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha